Hepatitis B Vaccination for a 78-Year-Old Male
A 78-year-old male should receive hepatitis B vaccination if he has specific risk factors for hepatitis B exposure, though universal vaccination is not routinely recommended at this age. 1
Age-Specific Vaccination Recommendations
The most recent ACIP guidelines (2022) establish clear age-based vaccination criteria 1:
- Ages 19-59 years: Universal hepatitis B vaccination is recommended for all adults, regardless of risk factors
- Ages ≥60 years: Vaccination is recommended only for those with identifiable risk factors for hepatitis B infection
- Adults ≥60 years without known risk factors may also receive hepatitis B vaccines, but this is permissive rather than a routine recommendation
Risk Factors That Warrant Vaccination at Age 78
Your 78-year-old patient should receive hepatitis B vaccination if he has any of the following 2, 3:
Sexual/Household Exposure Risks:
- Not in a long-term, mutually monogamous relationship
- More than one sex partner in the previous 6 months
- Seeking evaluation or treatment for sexually transmitted disease
- Household or sexual contact of a hepatitis B surface antigen-positive person
Medical/Healthcare Risks:
- End-stage renal disease or receiving hemodialysis
- HIV infection
- Chronic liver disease
- Requiring immunosuppressive therapy
- Healthcare personnel or public safety worker with potential blood exposure
Other Risks:
- Current or recent injection drug use
- International travel to countries with high or intermediate hepatitis B prevalence
- Incarceration
- Elevated ALT levels (≥30 IU/L for men)
Important Note: Even if your patient simply desires protection from hepatitis B infection without specific risk factors, vaccination may still be administered at the clinician's discretion 1, 2.
Vaccination Schedule Options
For adults ≥20 years old, several vaccine options are available 1:
Standard Options:
- Recombivax HB: 10 μg (1 mL) at 0,1, and 6 months
- Engerix-B: 20 μg (1 mL) at 0,1, and 6 months
- Heplisav-B: 20 μg (0.5 mL) at 0 and 1 month (2-dose series)
- PreHevbrio: 10 μg (1 mL) at 0,1, and 6 months
- Twinrix (combined hepatitis A and B): 20 μg (1 mL) at 0,1, and 6 months
Special Considerations for Immunocompromised Patients:
- Recombivax HB: 40 μg (1 mL) at 0,1, and 6 months
- Engerix-B: 40 μg (2 mL) at 0,1,2, and 6 months (4-dose series)
Key Clinical Considerations
Prevaccination Testing: In older adults with potentially high rates of previous hepatitis B exposure, consider prevaccination testing (HBsAg, anti-HBs, anti-HBc) to avoid unnecessary vaccination of already immune individuals 4. However, testing should never be a barrier to vaccination—administer the first dose immediately after collecting blood for testing.
Postvaccination Testing: Routine postvaccination serologic testing is not recommended for immunocompetent adults 4. Testing is reserved for specific high-risk groups: healthcare personnel, hemodialysis patients, HIV-infected persons, other immunocompromised individuals, and sex partners of HBsAg-positive persons 4.
Interrupted Series: If the vaccination series is interrupted, it does not need to be restarted 4. Simply continue with the next dose when feasible, maintaining appropriate intervals between doses.
Common Pitfalls to Avoid
- Don't assume all older adults need vaccination: Unlike the universal recommendation for ages 19-59, vaccination at age 78 requires either risk factor assessment or patient preference for protection
- Don't delay vaccination for testing results: If testing is performed, give the first vaccine dose immediately after blood draw
- Don't routinely check antibody titers after vaccination: This is unnecessary in immunocompetent older adults unless they fall into specific high-risk categories requiring documentation of immunity